Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial
media
posted on 2025-06-18, 13:59 authored by Ayataka Fujimoto, Bing Qin, Dimitrios Bourikas, Najla Dickson, Brian Moseley, Tomonobu Sano, Tadaharu Soma, Weiwei Sun, Jun Watanabe, Dong Zhou, Yushi Inoue
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above Graphical Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
